Partnership Limited GP Biofund Israel Orbimed Net Worth & Insider Trades
Partnership Limited GP Biofund Israel Orbimed Novus Therapeutics, Inc
What is Partnership Limited GP Biofund Israel Orbimed's Net Worth?
The current estimated net worth of Novus Therapeutics, Inc's Partnership Limited GP Biofund Israel Orbimed is estimated to be about $73.9M . Partnership Limited GP Biofund Israel Orbimed owns about 73,650 units of Novus Therapeutics, Inc common stock. In the last 3 years at Novus Therapeutics, Inc, Partnership Limited GP Biofund Israel Orbimed has sold an estimated value of $2.23M worth.
What is Partnership Limited GP Biofund Israel Orbimed's Past Insider Trading?
Partnership Limited GP Biofund Israel Orbimed's largest purchase order was 646,204 units , worth over $2M on May 6, 2019. Partnership Limited GP Biofund Israel Orbimed's largest sale order was 103,200 units , worth over $2.23M on December 4, 2020. In total, Partnership Limited GP Biofund Israel Orbimed has made about 4 transactions over 3 years of their time at Novus Therapeutics, Inc. Partnership Limited GP Biofund Israel Orbimed usually trades in May, with the busiest year in 2020.
OrbiMed Israel GP Ltd, Partnership Limited GP BioFund Israel OrbiMed
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Partnership Limited GP Biofund Israel Orbimed's' Mailing Address?
- Mailing address is 601 Lexington Avenue, 54th Floor New York NY 1022-4629 NY
What are Novus Therapeutics, Inc's Past Insider Trades?
Novus Therapeutics, Inc's most recent insider trade came on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed who sold 103,200 units worth $2.23M . In the last 3 years, insiders at Novus Therapeutics, Inc have sold an estimated value of $2.63M and bought an estimated value of $7.31M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are Catherine C Turkel, President, Gregory J Flesher, Chief Executive Officer, and Jon Kuwahara, See Remarks .
Eledon Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||